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Performing High-Risk Procedures
Perception or Reality?*Edward L. Hannan, PHD, MS, MST here is a large body of literature on the dan-gers of public reporting of health outcomes,and 1 of the primary dangers cited is the
avoidance of high-risk cases (1–4). It should be noted
that some reports on the avoidance of high-risk cases
may be inaccurate or overstated (5,6). Also, when
high-risk patients do not undergo invasive treatment,
it may be the appropriate decision, or they may soon
undergo treatment by a provider that is more experi-
enced and competent. Nevertheless, withholding of
appropriate treatment is a serious concern in the era
of public reporting that should be carefully examined
and addressed. This includes an investigation of the
ability of statistical models to accurately predict the
risk for seriously ill patients and an assessment of
the detrimental impact on providers that treat high-
risk patients.SEE PAGE 10In this issue of JACC: Cardiovascular Interventions,
Sherwood et al. (7) use 2010 data from the CathPCI
registry to examine the calibration of high- and low-
risk percutaneous coronary intervention (PCI) pa-
tients, to compare ratings of hospitals based on the
average level of risk of their patients, to calculate
observed/expected in-hospital mortality ratios, and
to assess the impact of combining all high-risk pa-
tients over a 2-year period into a single year on hos-
pital risk-adjusted mortality (RAM) ratings. Findings*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
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of this paper to disclose.were that the National Cardiovascular Data Registry
(NCDR) model used to risk adjust outcomes slightly
overpredicted risk for high-risk cases, hospitals
treating the highest-risk patients on average had
better RAMs than hospitals with lower-risk cases, and
combining all high-risk patients over a 2-year period
into a single year didn’t negatively impact hospitals’
RAM ratings.
Sherwood et al. (7) are to be congratulated for un-
dertaking this important work and for developing
methods to examine the impact on providers of
treating the highest-risk patients. It is notable that
they deﬁned “high-risk” in different ways, all of
which led to the same conclusion (that there is no
adverse impact on ratings of providers who treat
high-risk patients), and this is a conﬁrmation of their
ﬁndings. However, there are reasons why many PCI
providers who currently avoid high-risk procedures
may not be convinced to change in a climate of public
dissemination. First, the fact that sites that treat more
high-risk cases have better RAM ratings is not
necessarily a result of performing high-risk cases. It
could also be due to the fact that they are better
quality hospitals, both for high- and low-risk cases.
This competing hypothesis could be examined by
comparing their performance with other hospitals
separately for high- and low-risk cases. I realize that
this was theoretically done by combining high-risk
cases into a single year, but comparing hospitals
across high- and low-risk cases is a more clear-cut
and understandable way to test the competing
hypothesis.
Second, with regard to the concentrated risk-year
analysis, it is comforting to see that the observed/
expected ratios and number of outliers are similar to
what they are for the overall analysis, but it would be
of more interest to compare individual hospital
TABLE 1 Number of Cases and In-Hospital/30-Day Mortality for
Patients With Shock Undergoing PCI in New York: 2005 to 2011
N %* Deaths OMR
2005† 83 0.15 28 33.73
2006 133 0.23 56 42.11
2007 146 0.28 63 43.15
2008 138 0.25 70 50.72
2009 156 0.28 74 47.44
2010 161 0.30 78 48.45
2011 187 0.37 95 50.80
*% of cases with risk. †Shock exclusion policy instituted in 2006.
OMR ¼ observed in-hospital/30-day mortality rate for cases with risk.
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18ratings with the 2 sets of analyses. What is of most
concern to hospitals and physicians is how their own
rating is impacted by high-risk cases.
Perhaps my skepticism of the ability of the Sher-
wood et al. (7) ﬁndings to change current practice is a
result of my own inability to be persuasive in this
regard. In 2006, the New York State Department of
Health convened “town hall” meetings for the pur-
pose of educating physicians and hospitals about the
cardiac registries, risk adjustment, and among other
things, the impact of high-risk cases on hospital and
cardiologist ratings. At that time, the primary
complaint about inclusion of high-risk cases in public
reporting centered around the reporting of shock
patients. The method I used to make the argument
that ratings are unaffected by the inclusion of shock
patients was to develop separate statistical models
with and without shock patients included, and then
to compare hospital and physician RAM ratings, and
outlier status for the 2 models. The ﬁndings for both
PCI and coronary artery bypass graft (CABG) surgery
were that more hospitals and more physicians had
better, rather than worse, observed/expected ratios
for shock cases than for other cases, and that the
outliers for PCI and CABG were identical when shock
cases were taken out of the databases and new sta-
tistical models were created.
These arguments were not effective in quelling the
concerns expressed by hospitals and physicians, and
in response to continued concerns about the detri-
mental impact of including shock patients in the PCI
and CABG surgery registries, the New York State
Department of Health decided to eliminate shock
patients from public reporting as of January 2006. It
should be noted that shock is deﬁned more restric-
tively in New York, and is more similar to what is
regarded as refractory shock in other databases (and
will be referred to as refractory shock in New York as
of 2015). Shock is deﬁned in New York’s registries as
acute hypotension (systolic blood pressure <80
mm Hg) or low cardiac output (<2.0 l/min/m2) despite
pharmacological or mechanical support. It can be
coded if the patient has ongoing resuscitation or has a
ventricular assist device.
Table 1 demonstrates the impact on the number of
patients with shock undergoing PCI in New York
between 2005 and 2011.
As indicated, the number of patients rose sub-
stantially in the ﬁrst year of the exclusion (from 83 to
133) and has been rising almost steadily since then. In
2012, the number was more than double of what it
was in 2005 when shock cases were publicly reported.
Although there are many possible reasons for this
increase, including improved emergency medicalservice policies and more transfers and direct trans-
ports to PCI hospitals, these data do suggest that the
policy of excluding shock from public reporting has
enabled more shock patients to undergo PCI, which is
the best treatment for most of them. The fact that the
mortality rate has risen for these patients is arguably
an indication that the additional patients in subse-
quent years are a higher-risk group of patients on
average than the patients undergoing PCI before the
exclusion.
Recently, a group of cardiologists in New York
requested that the Department of Health expand the
criteria for excluding shock patients so that patients
with acute hypotension or low cardiac index that do
not have either pharmacological or mechanical sup-
port would also be excluded. The Department of
Health consulted its Cardiac Advisory Committee
(CAC), consisting of cardiac surgeons, cardiologists,
and other clinical experts within and outside of New
York, and the CAC advised against expanding the
exclusion.
Since 2011, New York has also excluded a subset of
patients with anoxic encephalopathy from public
reporting in its PCI registry. The criteria include PCI
done for acute myocardial infarction, documented
cardiac arrest before arrival at the catheterization
laboratory, coma following the cardiac arrest, no in-
lab death, persistent severe hypoxic encephalopathy
present at the time of death or the decision to with-
hold or withdraw care, and medical record docu-
mentation of a post-PCI consultation by neurology or
critical care documenting the presence and severity
of anoxic/hypoxic encephalopathy. There have also
been inquiries to the Department of Health to expand
this deﬁnition, but on the advice of its CAC, the
Department has chosen not to do so.
The decision to exclude high-risk patients from
public reporting is a difﬁcult one, particularly for a
procedure like PCI for which short-term mortality is
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19so low with high-risk patients excluded. For example,
in New York in 2011, the mortality rate for PCI pa-
tients without shock, hemodynamic instability, or an
acute myocardial infarction in the 24 h before the
procedure was 0.65%. When high-risk patients are
excluded, the number of patients that are publicly
reported may not decrease much, but the number of
deaths could decrease substantially, and this makes it
difﬁcult to meaningfully compare hospitals (8).
In my view, if risk factors are to be considered for
exclusion in public reporting, the following are 3
conditions that should be present.
1. The risk factor should have a severe adverse
outcome (mortality for most reports) rate. This is
because it is high-risk cases that are perceived to be
detrimental to a provider’s ratings (although this is
not necessarily true).
2. The risk factor should be relatively rare. This is
important because if a risk factor has a high mor-
tality rate and a low prevalence, a death may be
difﬁcult to recover from without the opportunity to
have many similar high-risk cases in the reporting
period. For example, if a shock patient dies, the
decrement to the hospital for that 1 case is roughly
1.0 (death)  0.50 (probability of death) ¼ 0.5. To
make up for that decrement with elective patientshaving an average mortality rate of 1% (0.01), it
would take 50 straight cases without a short-term
death.
3. The risk factor should be such that the risk for any
given patient may be difﬁcult to estimate accu-
rately. For instance, it could be argued that the
probability of mortality for a given shock patient as
deﬁned in the preceding text is difﬁcult without
knowing the patient’s precise systolic blood pres-
sure or cardiac index at various times before un-
dergoing PCI.
In conclusion, the efforts of Sherwood et al. (7) to
clarify the impact on provider ratings of performing
high-risk PCI cases should be applauded. Government
agencies and other rating organizations, health policy
experts, and analysts need to be armed with this type
of information when making decisions about crafting
public reports that rate providers, and this informa-
tion should be shared and discussed with providers
that are being rated.
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